Industry Day 2014 Details

Conference Program

MORNING SESSION

8:30  –  9:30 am
Registration and hang posters

9:30  –  9:45 am
Opening Remarks: Drs. Kevil and Guillbeau

9:45 – 10:25 am
Recreating Human Disease Biology for Discovery and Development of Safer and More Effective New Drugs
Dr. Brian R. Wamhoff
VP of Research and Development, HemoShear

Selected Local Speakers:

10:30- 10:45 am
Longitudinal Studies in Rodent Models Using Implanted Micro-Optic Lenses
Dr. Teresa Murray, Assistant Professor,
CBERS, Louisiana Tech University

10:50- 11:15 am
Development of an electromechanical apparatus for the controlled stretching of cells in culture
Dr. Kevin McCarthy
Professor and Director, Division of Research
Dept of Pathology, LSU Health Shreveport

11:20- 11:35 am
Toward the development of a drug eluting stent: Challenges, pitfalls and opportunities for commercializing research through NIH funding?
Dr. Tammy Dugas, Professor
Dept of Pharmacology, LSU Health Shreveport

11:40- 11:55 am
Hand-held Hydrogen Sulfide Sensing for Environmental and Biomedical Use: LSUHSC – LA Tech collaborative research
Dr. Leland Weiss, Thurman Lauret Associate Professor
Mechanical Engineering, Louisiana Tech University

 

12:00  – 1:00 pm
LUNCH

 

AFTERNOON SESSION

1:05  –  1:10 pm
Introduction:  Dr. Guillbeau

1:10  –  1:50 pm
The Development of the Total Bioficial Heart:  The Value of Industry-Academic Relationships
Dr. Stuart K. Williams
Division Chief, Bioficial Heart

1:55  –  2:00 pm
Closing remarks:  Dr. Kevil

2:00  –  3:30 pm
Poster session

3:35 pm
Adjourn conference

Keynote Speakers


Brian R. Wamhoff, PhD

Vice President of Research and Development.   Dr. Wamhoff is co-founder of HemoShear and co-inventor of its technology. He is an Associate Professor at the University of Virginia (UVa) in the Cardiovascular Division of UVa’s Department of Medicine, with a joint appointment in Biomedical Engineering. Dr. Wamhoff has expertise in small and large animal models of vascular disease, molecular biology and cell-based systems and interventional vascular device development. He has obtained funding from the NIH, the pharmaceutical industry, the American Heart Association, and other organizations to study fundamental mechanisms that regulate smooth muscle cell biology vascular disease. Dr. Wamhoff has authored more than 50 peer-reviewed manuscripts, as well as several book chapters and commentaries. Dr. Wamhoff has also received multiple awards for his successes, including the 2004 American Physiological Society Cardiovascular Young Investigator Award, the 2008 Atherosclerosis, Thrombosis, and Vascular Biology (ATVB) Irvine H. Page Award, the 2010 American Physiological Society New Investigator Award for Cardiovascular Research and the 2011 Rhodes College Distinguished Alumni Award, his alma mater. Dr. Wamhoff obtained a BS in Biology with a minor in Business Administration from Rhodes College in 1996 and received his PhD in Medical Physiology from the University of Missouri in 2001.

 

Stuart K. Williams, PhD
Division Chief, Bioficial Heart. Dr. Stuart Williams received his Ph.D. in cell biology from the University of Delaware, followed by postdoctoral training in pathology at the Yale School of Medicine. During the period 1980 to 1990 he held a faculty appointment at Jefferson Medical College, where he was director of research in the department of surgery. In 1990 Dr. Williams joined the faculty at the University of Arizona and established the section of surgical research in the department of surgery. In 1997 he founded the University of Arizona biomedical engineering program, creating a research and educational link between the medical school and the college of engineering. He held faculty positions jointly in biomedical engineering, surgery, physiology and materials science and engineering.  Dr. Williams’ research interests have focused on medical devices, regenerative medicine and infection control. He developed and patented the first methods to use fat-derived stem cells for therapeutic use. He has maintained continuous funding from the National Institutes of Health since 1979.  Dr. Williams has authored over 300 scientific publications. His entrepreneurial spirit has resulted in 16 issued US patents with numerous patents pending. He has founded three biotechnology companies, maintained active managerial positions and has been an active consultant to the medical device and pharmaceutical community. He is a fellow of the American Heart Association and a fellow of the American Institute of Medical and Biological Engineering.